WiSeed

WiSEED is a crowdfunding platform founded in 2008 by Nicolas Seres and Thomas Merquiol, based in Toulouse, that allows users to invest in SMEs and enterprises. The platform offers investment opportunities in startups, real estate, social innovation, renewable energy projects, and agriculture firms, providing a diverse range of options for individuals looking to support and fund various businesses and projects.

Thierry MERQUIOL

Co-Founder and Chairman of the board

Nicolas SÉRÈS

Co-Founder and CEO

30 past transactions

BiPER Therapeutics

Debt Financing in 2024
BiPER Therapeutics is a biotechnology company focused on developing and commercializing innovative therapeutics. The company specializes in creating drugs that target critical proteins involved in the metabolism of cancer cells, aiming to address treatment resistance and enhance cancer cell survival. Its therapeutic offerings are particularly aimed at the treatment of gastrointestinal cancers, providing potential solutions for patients facing these challenging conditions.

Vaxinano

Venture Round in 2024
Vaxinano is a biotechnology company focused on the preclinical and pharmaceutical development of vaccines and drug delivery systems for both humans and animals. Established in 2016, Vaxinano builds on 25 years of research and clinical trials related to vaccines, utilizing the patented technology of Pr Didier Betbeder. The company specializes in creating safe-by-design nanoparticles that adhere to green chemistry principles, which support the development of prophylactic and therapeutic vaccines for infectious diseases. Additionally, Vaxinano aids medical researchers in formulating drugs that activate biomolecules, proteins, and antigens, thereby facilitating innovative approaches to combat untreated viral, bacterial, and parasitic diseases.

BiPER Therapeutics

Seed Round in 2023
BiPER Therapeutics is a biotechnology company focused on developing and commercializing innovative therapeutics. The company specializes in creating drugs that target critical proteins involved in the metabolism of cancer cells, aiming to address treatment resistance and enhance cancer cell survival. Its therapeutic offerings are particularly aimed at the treatment of gastrointestinal cancers, providing potential solutions for patients facing these challenging conditions.

Dianosic

Seed Round in 2023
Dianosic SAS, founded in 2017 and based in Strasbourg, France, specializes in developing advanced medical devices for Ear, Nose, and Throat (ENT) conditions. The company has created CAVI-T, an innovative intranasal balloon designed to stop spontaneous or postoperative bleeding through low-pressure compression, while also preventing biofilm formation and enhancing healing. Additionally, Dianosic is working on the Active Resorbable Intranasal Scaffold (ARIS), a groundbreaking treatment for chronic sinusitis and allergic rhinitis, which offers a long-lasting drug-eluting solution that can last from six to twelve months. This technology not only addresses patient compliance challenges but also presents opportunities for expanding treatment options in related areas such as chronic migraine and facial pain. Through its cutting-edge solutions, Dianosic aims to redefine standards of care in ENT healthcare.

VistaCare Medical

Venture Round in 2022
VistaCare is a French company specializing in the development, manufacturing, and distribution of medical devices designed for the treatment of acute and chronic wounds. The company focuses on innovative, non-contact treatment methods that operate in a controlled environment. Their technology addresses critical aspects of wound care, including the reduction of nosocomial risks, visual monitoring of wound progression, and tailored medical protocols based on the specific type and stage of each wound. By enhancing the quality of life for patients and streamlining the care process for caregivers, VistaCare aims to significantly reduce treatment times and hospital stays, offering a more effective solution for complex wounds that are challenging to manage with conventional therapies.

Biointrant

Venture Round in 2022
BioIntrant specializes in enhancing agricultural productivity through innovative solutions in biotechnology and related fields. The company develops biofertilizers designed to improve profitability while adhering to environmentally responsible practices in modern agriculture. By integrating plants with their surrounding environment, BioIntrant's products bolster plants' innate defense mechanisms, thereby promoting overall plant health and productivity. Their services encompass a range of disciplines, including agronomy, microbiology, biostimulation, bioinformatics, and genomics, all aimed at advancing sustainable agricultural practices.

Spartha Medical

Seed Round in 2021
SPARTHA Medical is a medical technology company focused on developing innovative coatings that enhance the safety of medical devices and consumer products by protecting against microbial and inflammatory risks. The company utilizes natural biopolymers to create invisible, eco-friendly, and biocompatible coatings that possess antibacterial, antiviral, and anti-inflammatory properties. By employing a patented technology that allows for the precise control of the assembly of two different polyelectrolytes, SPARTHA Medical's products can be tailored to meet diverse requirements across various fields. These multifunctional and easy-to-apply coating solutions aim to help healthcare institutions maintain disease-free surfaces on medical devices, thereby enhancing patient safety and reducing infection risks.

WattPark

Seed Round in 2021
WattPark specializes in providing charging point solutions for the automobile industry. The company offers reservable and monetizable charging stations that enable users to select specific locations and associated services via Bluetooth. This innovative approach allows automobile clients to access parking devices and charging solutions in areas lacking network coverage or internet connectivity. WattPark's mobile application fully controls the booking process, enhancing user convenience and facilitating efficient charging experiences.

uvoji by T.zic

Seed Round in 2020
uvoji designs, develops, manufactures and markets all-in-one solutions for the treatment and disinfection of water at points of use and of surfaces by UV LEDs. To meet the major challenges of access to drinking water and provide technological solutions to the urgent needs of point-of-use water treatment, we launched the Oji Safe, Oji Pure and Oji Reuse products. Our solutions are used notably by the French Red Cross for its operations. In response to the Covid pandemic, we developed the Uvo Care. Uvo Care is the disinfection box, Made in France, for all types of masks and everyday objects. The essential ally for resuming your professional activities in complete safety. It has been tested and approved by independent laboratories and kills over 99.999% of viruses and bacteria in just seconds (including SARS-COV2 virus).

Lumi'In

Venture Round in 2019
Lumi'In is a manufacturer based in Malijai, France, specializing in smart solar streetlights for public and private spaces. Established in 2014, the company designs, assembles, and distributes a range of solar lighting solutions, including various models such as Frisbi, Caraibe, Astral, Classic, and Wave. Lumi'In's products utilize photovoltaic modules to generate and store electric energy, providing an environmentally friendly alternative to traditional street lighting. In addition to its lighting systems, the company offers services such as on-site visits, brightness simulations, product customization, and power-tuning to meet customer needs.

gulplug

Equity Crowdfunding in 2019
Gulplug is a technology company based in Grenoble, France, established in 2014, specializing in solutions for electrical connections to power grids and the Internet. Its offerings include a range of innovative products such as E-Cube wireless energy sensors, E-Case—a standalone suitcase that collects and transmits energy consumption data, and SELFPLUG, a rechargeable socket designed for electric vehicles. Gulplug also provides a web platform called Cleantech Save It Yourself, which facilitates monitoring of machine energy usage. The company focuses on energy efficiency and the Internet of Things, delivering smart plugs that feature a magnetic hold and water-resistant design. These products cater to various industries, emphasizing safety, convenience, and energy savings, and the company also offers co-innovation services to customize its solutions to meet specific client needs.

Lattice Medical

Seed Round in 2018
Lattice Medical is a medical technology company based in Loos, France, founded in 2017. The company specializes in the design and manufacture of innovative prostheses for women who have undergone mastectomy due to breast cancer. Its flagship product, MATTISSE, addresses significant clinical and societal needs by enabling natural breast reconstruction. MATTISSE uses a combination of biomaterials and tissue engineering, including 3D printing, to create custom implants that regenerate autologous adipose tissue. This technology allows for a single surgical procedure, as the fully biodegradable implants dissolve after reconstruction, minimizing invasiveness and pain while reducing surgery time. Lattice Medical aims to replace traditional silicone-based implants with its advanced solutions, thereby enhancing the quality of life for women affected by breast cancer.

ffly4u

Venture Round in 2018
ffly4u SAS provides innovative solutions for tracking reusable mobile assets and transport packaging, specializing in low-frequency locating services. Founded in 2014 and based in Toulouse, France, the company offers several applications, including myDrum, myBin, myTrailer, and myEquipment, which facilitate both outdoor and indoor geolocation of various assets. These solutions cater to a wide range of industries, such as telecommunications, waste management, construction, and agriculture, by serving logistics and supply chain managers, as well as financial and operational executives. The technology combines a device for asset attachment, low-power wide-area network (LPWAN) connectivity for data transmission, and a data platform powered by ThingWorx for effective data management. This comprehensive approach positions ffly4u as a leader in embedded information for B2B mobile assets in Europe.

Virage-Viager

Venture Round in 2018
Virage-Viager, founded in 2010 and based in Paris, France, specializes in providing life insurance solutions tailored for senior citizens. The company focuses on fostering intergenerational savings, enabling seniors to maintain financial stability and quality of life as they age. Through its innovative approach, Virage-Viager aims to address the financial needs of older adults while promoting equity and support within families.

Levels3D

Series A in 2018
Levels3D is a French startup founded in 2012 by Yannick Folliard, specializing in 3D and augmented reality solutions. The company develops innovative software for real-time 3D scanning, particularly through its MyCaptR application, aimed at professionals such as consulting firms, architects, general contractors, and space designers. This application is designed for next-generation tablets and smartphones equipped with depth sensors, enabling users to create and manage 3D scans efficiently. Additionally, Levels3D is working on Smart Glasses-ERDF, a prototype augmented reality device that enhances the 3D scanning experience.

Pili

Venture Round in 2018
PILI Inc. is a company based in Paris, France, that specializes in researching and manufacturing bio-fabricated colors derived from microorganisms. Founded in 2012, the company focuses on designing enzymes and fermentation biotechnologies that convert sugar into sustainable and long-lasting dyes and pigments. PILI produces renewable inks as an eco-friendly alternative to traditional toxic and non-recyclable options. The company emerged from a collaboration among a biologist, a designer, and a financial analyst in a biohacker space, leading to the creation of innovative products like a pen fed by bacteria. By utilizing microorganisms, PILI aims to replace petrochemical and non-sustainable vegetable dyes, promoting sustainable development while also helping businesses reduce costs.

Poietis

Series A in 2018
Poietis is a biotechnology company focused on developing and manufacturing human tissues through 4D laser bioprinting. The company provides a platform for industrial stakeholders and researchers to create bio-printed products tailored for regenerative medicine, preclinical research, and the evaluation of cosmetic ingredients. Poietis is advancing the development of 3D physiological models that facilitate more accurate in vitro assessments of drug toxicity and efficacy, collaborating with major pharmaceutical and cosmetic companies, including projects like the bioprinting of hair follicles with L'Oréal. The company also offers a single-cell bioprinting platform, ensuring that tissue bioprinting processes meet industrial production requirements and clinical manufacturing standards, thereby enhancing the versatility and range of biomaterials available for research and development in personalized medicine.

1Check

Venture Round in 2017
1Check is a cloud-based SaaS platform and mobile application that specializes in operations management for the hospitality sector. Founded in 2012 by industry experts, it addresses the unique requirements of housekeeping, maintenance, and management teams. The platform enables managers to efficiently organize and schedule cleaning and maintenance teams for accommodation and tourism activities, enhancing customer service quality and boosting team productivity. With a presence at over 350 client sites across Europe, 1Check is recognized for its user-friendly technology that not only improves operational efficiency but also enhances customer satisfaction and working conditions for staff.

Vectalys

Venture Round in 2016
Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies. Vectalys has developed a state-of-the-art proprietary technology to provide the highest quality of lentiviral vectors for the transduction of hard-to-transfect cells like primary cells, stem cells and in vivo tissues. Vectalys high quality lentiviral vectors ensure 100% transduction efficiency and non-toxic transduction on any target cells, for example to create predictive models. Because each project is unique, the Vectalys team supports you by providing custom lentiviral vectors for the right application with your gene of interest. Vectalys is also the manufacturer of highly pure ready-to-use lentiviral vectors carrying fluorescent, bioluminescent or gene editing proteins. These products are distributed worldwide. Vectalys is committed to providing solutions that save your time and support your most ambitious projects.

SUNiBrain

Venture Round in 2016
SUNiBrain is a company that specializes in innovative cooling systems for photovoltaic panels, aimed at enhancing the performance and longevity of solar cells. By utilizing a natural rainwater cooling method, SUNiBrain effectively reduces the aging of solar cells and protects them from extreme temperatures, thereby ensuring optimal photoelectric efficiency consistently over time. This patented technology provides significant profitability for solar power producers, allowing them to achieve higher annual production rates. SUNiBrain's solutions are compatible with all types of photovoltaic installations, making it a versatile option for professionals in the solar energy sector.

Algo Paint

Equity Crowdfunding in 2016
Algo Paint SA, founded in 2015 and located in Vern-sur-Seiche, France, specializes in the manufacture of eco-friendly paints derived from algae. By utilizing renewable local resources, the company replaces fossil fuels in its production process. The algae-based paints serve as a healthier alternative to traditional chemical paints, suitable for both interior and exterior applications. This innovative approach not only enhances air quality but also aligns with environmental standards and regulations in various countries, promoting sustainability in the paint industry.

StayHome SAS

Seed Round in 2016
StayHome SAS operates a real estate portage platform that supports private individuals in executing rental investments while providing assistance to property owners facing financial difficulties. The platform enables owners to temporarily sell their real estate to raise capital for debt management. Importantly, it allows these owners to remain tenants in their properties, with an agreement to repurchase the property at a predetermined price within a specified timeframe. The company’s solutions are designed to be accessible, offering flexible financing without age, health, or income criteria, catering to private and professional owners who may not qualify for traditional bank financing. Through this approach, StayHome facilitates affordable housing options for its users.

Poietis

Equity Crowdfunding in 2016
Poietis is a biotechnology company focused on developing and manufacturing human tissues through 4D laser bioprinting. The company provides a platform for industrial stakeholders and researchers to create bio-printed products tailored for regenerative medicine, preclinical research, and the evaluation of cosmetic ingredients. Poietis is advancing the development of 3D physiological models that facilitate more accurate in vitro assessments of drug toxicity and efficacy, collaborating with major pharmaceutical and cosmetic companies, including projects like the bioprinting of hair follicles with L'Oréal. The company also offers a single-cell bioprinting platform, ensuring that tissue bioprinting processes meet industrial production requirements and clinical manufacturing standards, thereby enhancing the versatility and range of biomaterials available for research and development in personalized medicine.

Naïo Technologies

Seed Round in 2015
Naïo Technologies SAS, founded in 2011 and based in Ramonville Saint Agne, France, specializes in designing and developing electric tools for agriculture and viticulture. The company focuses on creating robots that assist in mechanical weeding, hoeing, and harvesting, thereby improving farming efficiency and reducing reliance on chemical pesticides and herbicides. Through its innovative solutions, Naïo Technologies aims to help farmers optimize their workloads, enhance profitability, and minimize environmental impact. The firm’s commitment to integrating advanced technologies in agriculture highlights its role in promoting sustainable farming practices.

GAIDDON

Seed Round in 2015
Founded in 2010 by 4 entrepreneurs, GAIDDON Software SAS is a simplified joint-stock company registered under French law with a share capital of 161,100 Euros. It is based in Toulouse, south of France. GAIDDON Software is integrated within the Toulouse Metropole business incubator since its creation. In 2011, the company gained the french label “Jeune Entreprise Innovante” from the ministry of higher education and research. It indicates that most of the work done by the company is an innovative research and development. This innovative work is our 3D environment builder technology from aerial/satellite imagery.

MyFeelBack

Venture Round in 2014
MyFeelBack is a developer of an advanced online survey and feedback platform that enables businesses to gather valuable customer insights. The platform allows companies to create targeted surveys and display personalized messages, effectively keeping customer databases up-to-date. By capturing crucial feedback, businesses can make informed, data-driven decisions, identify areas for improvement, and recognize trends that may affect revenue. This approach empowers organizations to enhance customer understanding and implement personalized marketing strategies, ultimately driving sales conversion and fostering growth.

Antabio

Seed Round in 2012
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing novel treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating antibacterial resistance-breakers that can restore the efficacy of existing antibiotics. Its key innovation includes inhibitors of bacterial metalloenzymes, specifically Metallo ß-lactamases (MBLs), which are designed to be used in combination with carbapenems to address significant treatment gaps in drug-resistant nosocomial infections. Antabio aims to provide health professionals with effective medicinal products to combat life-threatening respiratory infections, including carbapenem-resistant pneumonia and chronic pulmonary diseases. The company has received recognition for its research efforts, including a Wellcome Trust Seeding Drug Discovery Award.

Intuiface

Seed Round in 2011
Intuiface is a no-code platform that enables the creation, integration, deployment, and analysis of interactive digital experiences tailored for physical spaces. Serving over 1,600 companies in more than 70 countries, it facilitates the connection between people and places through various interactive technologies, including touch, RFID/NFC, computer vision, and IoT. The platform is versatile, applicable across multiple industries such as retail, hospitality, real estate, tourism, and education, and supports a wide range of applications, from digital signage to self-service kiosks. Intuiface is also ISO 27001 Certified, ensuring a high standard of security for its users.

Antabio

Seed Round in 2011
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing novel treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating antibacterial resistance-breakers that can restore the efficacy of existing antibiotics. Its key innovation includes inhibitors of bacterial metalloenzymes, specifically Metallo ß-lactamases (MBLs), which are designed to be used in combination with carbapenems to address significant treatment gaps in drug-resistant nosocomial infections. Antabio aims to provide health professionals with effective medicinal products to combat life-threatening respiratory infections, including carbapenem-resistant pneumonia and chronic pulmonary diseases. The company has received recognition for its research efforts, including a Wellcome Trust Seeding Drug Discovery Award.

Noomeo

Venture Round in 2009
Noomeo is an innovative company established in 2007, specializing in the development and marketing of 3D scanning tools and digital image processing solutions. The company focuses on providing user-friendly and ultra-portable systems that enable businesses to incorporate non-contact 3D digitization into their operations efficiently and cost-effectively. Through in-house research and development, as well as collaborations with research institutions, Noomeo continuously advances its technology offerings. The company has created OptiNum hardware solutions and NumiSoft software solutions, which facilitate the automatic creation of 3D mock-ups, positioning Noomeo as a leader in the 3D digitization sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.